{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T07:03:20Z","timestamp":1791443000032,"version":"4.3.3"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Veterinary Parasitology"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.vetpar.2024.110113","type":"journal-article","created":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T23:08:21Z","timestamp":1705014501000},"page":"110113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Fosfatriclaben, a prodrug of triclabendazole: Preparation, stability, and fasciolicidal activity of three new intramuscular formulations"],"prefix":"10.1016","volume":"327","author":[{"given":"Miguel","family":"Flores-Ramos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerardo","family":"Leyva-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania","family":"Rojas-Campos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Cruz-Mendoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Hern\u00e1ndez-Campos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yolanda","family":"Vera-Montenegro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Castillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Israel","family":"Vel\u00e1zquez-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Padierna-Mota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Arias-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Froyl\u00e1n","family":"Ibarra-Velarde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vetpar.2024.110113_bib1","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1007\/s00436-020-06705-4","article-title":"Efficiency comparison of experimental fosfatriclaben with three commercial fasciolicides in experimentally infected sheep","volume":"119","author":"Arias-Garc\u00eda","year":"2020","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.vetpar.2024.110113_bib2","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.aca.2016.05.014","article-title":"Simultaneous extraction and determination of albendazole and triclabendazole by a novel syringe to syringe dispersive liquid phase microextraction-solidified floating organic drop combined with high performance liquid chromatography","volume":"932","author":"Asadi","year":"2016","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.vetpar.2024.110113_bib3","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.jpba.2008.06.013","article-title":"Stability studies of anticancer agent bis(4-fluorobenzyl)trisulfide and synthesis of related substances","volume":"48","author":"Bao","year":"2008","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.vetpar.2024.110113_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.envpol.2020.116106","article-title":"Environmental risk assessment of the anthelmintic albendazole in Eastern Africa, based on a systematic review","volume":"269","author":"Belew","year":"2021","journal-title":"Environ. Pollut."},{"key":"10.1016\/j.vetpar.2024.110113_bib5","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1136\/vr.113.14.315","article-title":"Treatment of immature and mature Fasciola hepatica infections in sheep with triclabendazole","volume":"113","author":"Boray","year":"1983","journal-title":"Vet. Rec."},{"key":"10.1016\/j.vetpar.2024.110113_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.pt.2020.12.003","article-title":"Current challenges for fasciolicide treatment in ruminant livestock","author":"Castro-Hermida","year":"2021","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.vetpar.2024.110113_bib7","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0378-5173(97)00386-4","article-title":"Development of in situ gelling and mucoadhesive acetaminophen liquid suppository","volume":"165","author":"Choi","year":"1998","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.vetpar.2024.110113_bib8","first-page":"159","article-title":"Poloxamer: a novel functional molecule for drug delivery and gene therapy","volume":"5","author":"Devi","year":"2013","journal-title":"J. Pharm. Sci. Res"},{"key":"10.1016\/j.vetpar.2024.110113_bib9","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1007\/s11095-006-9104-4","article-title":"A review of poloxamer 407 pharmaceutical and pharmacological characteristics","volume":"23","author":"Dumortier","year":"2006","journal-title":"Pharm. Res."},{"key":"10.1016\/j.vetpar.2024.110113_bib10","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s11096-006-9069-8","article-title":"Effect of fascioliasis on the pharmacokinetic parameters of triclabendazole in human subjects","volume":"29","author":"El-Tantawy","year":"2007","journal-title":"Pharm. World Sci."},{"key":"10.1016\/j.vetpar.2024.110113_bib11","first-page":"339","article-title":"Applications of thermo-reversible pluronic F-127 gels in pharmaceutical formulations","volume":"9","author":"Escobar-Ch\u00e1vez","year":"2006","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.vetpar.2024.110113_bib12","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1079\/JOH2005298","article-title":"Triclabendazole: new skills to unravel an old(ish) enigma","volume":"79","author":"Fairweather","year":"2005","journal-title":"J. Helminthol."},{"key":"10.1016\/j.vetpar.2024.110113_bib13","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1136\/vr.d2867","article-title":"Raising the bar on reporting \u201ctriclabendazole resistance","volume":"168","author":"Fairweather","year":"2011","journal-title":"Vet. Rec."},{"key":"10.1016\/j.vetpar.2024.110113_bib14","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.vetpar.2011.05.034","article-title":"Reducing the future threat from (liver) fluke: realistic prospect or quixotic fantasy","volume":"180","author":"Fairweather","year":"2011","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.vetpar.2024.110113_bib15","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1053\/tvjl.1999.0377","article-title":"Fasciolicides: efficacy, actions, resistance and its management","volume":"158","author":"Fairweather","year":"1999","journal-title":"Vet. J."},{"key":"10.1016\/j.vetpar.2024.110113_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpddr.2019.11.003","article-title":"Drug resistance in liver flukes","author":"Fairweather","year":"2020","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"10.1016\/j.vetpar.2024.110113_bib17","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.bmcl.2016.12.004","article-title":"Novel triclabendazole prodrug: a highly water soluble alternative for the treatment of fasciolosis","volume":"27","author":"Flores-Ramos","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.vetpar.2024.110113_bib18","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1002\/ddr.21953","article-title":"Phosphate moiety in FDA-approved pharmaceutical salts and prodrugs","volume":"83","author":"Fulmali","year":"2022","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.vetpar.2024.110113_bib19","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.rvsc.2010.04.009","article-title":"The effect of fasting on the plasma disposition of triclabendazole following oral administration in goats","volume":"89","author":"Gokbulut","year":"2010","journal-title":"Res. Vet. Sci."},{"key":"10.1016\/j.vetpar.2024.110113_bib20","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.trac.2017.08.014","article-title":"Recent advances in liquid-phase microextraction techniques for the analysis of environmental pollutants","volume":"97","author":"Hashemi","year":"2017","journal-title":"TrAC Trends Anal. Chem."},{"key":"10.1016\/j.vetpar.2024.110113_bib21","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1021\/jm701260b","article-title":"Prodrugs of phosphates and phosphonates","volume":"51","author":"Hecker","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.vetpar.2024.110113_bib22","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0378-5173(03)00287-4","article-title":"Enzyme-mediated precipitation of parent drugs from their phosphate prodrugs","volume":"261","author":"Heimbach","year":"2003","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.vetpar.2024.110113_bib23","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1365-2885.1987.tb00078.x","article-title":"The kinetics of triclabendazole disposition in sheep","volume":"10","author":"Hennessy","year":"1987","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"10.1016\/j.vetpar.2024.110113_bib24","first-page":"1","article-title":"Field study on the determination of the effective dose of injectable fosfatriclaben prodrug in sheep naturally infected with Fasciola hepatica","volume":"1","author":"Ibarra-Velarde","year":"2021","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.vetpar.2024.110113_bib25","first-page":"1","article-title":"The prodrug approach: a successful tool for improving drug solubility","volume":"21","author":"Jornada","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.vetpar.2024.110113_bib26","doi-asserted-by":"crossref","unstructured":"Jouyban, A., 2009. Handbook of Solubility Data for Pharmaceuticals.","DOI":"10.1201\/9781439804889"},{"key":"10.1016\/j.vetpar.2024.110113_bib27","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0168-3659(02)00009-3","article-title":"Pluronic (R) block copolymers as novel polymer therapeutics for drug and gene delivery","volume":"82","author":"Kabanov","year":"2002","journal-title":"J. Control. Release"},{"key":"10.1016\/j.vetpar.2024.110113_bib28","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1517\/13543784.14.12.1513","article-title":"Triclabendazole for the treatment of fascioliasis and paragonimiasis","volume":"14","author":"Keiser","year":"2005","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.vetpar.2024.110113_bib29","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1365-2885.1988.tb00150.x","article-title":"Pharmacokinetics and efficacy of triclabendazole in goats with induced fascioliasis","volume":"11","author":"Kinab","year":"1988","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"10.1016\/j.vetpar.2024.110113_bib30","series-title":"in: The Laboratory Rat","first-page":"587","article-title":"Experimental modeling and research methodology","author":"Koch","year":"2006"},{"key":"10.1016\/j.vetpar.2024.110113_bib31","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0169-409X(95)00111-J","article-title":"Prodrugs of phosphates, phosphonates, and phosphinates","volume":"19","author":"Krise","year":"1996","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.vetpar.2024.110113_bib32","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1021\/js9803813","article-title":"A novel prodrug approach for tertiary amines. 2. Physicochemical and in vitro enzymatic evaluation of selected N-phosphonooxymethyl prodrugs","volume":"88","author":"Krise","year":"1999","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.vetpar.2024.110113_bib33","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ijpharm.2005.10.004","article-title":"Development of parenteral formulations and evaluation of the biological activity of the trypanocide drug benznidazole","volume":"307","author":"Lamas","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.vetpar.2024.110113_bib34","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1046\/j.1365-2125.1998.00725.x","article-title":"Effect of food on the bioavailability of triclabendazole in patients with fascioliasis","volume":"45","author":"Lecaillon","year":"1998","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.vetpar.2024.110113_bib35","article-title":"Alkaline phosphatase: a reliable endogenous partner for drug delivery and diagnostics","volume":"5","author":"Le-Vinh","year":"2022","journal-title":"Adv. Ther."},{"key":"10.1016\/j.vetpar.2024.110113_bib36","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.ijpara.2005.07.010","article-title":"Fascioliasis and other plant-borne trematode zoonoses","volume":"35","author":"Mas-Coma","year":"2005","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.vetpar.2024.110113_bib37","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0065-308X(09)69002-3","article-title":"Chapter 2 Fasciola, lymnaeids and human fascioliasis, with a global overview on disease transmission, epidemiology, evolutionary genetics, molecular epidemiology and control","volume":"69","author":"Mas-Coma","year":"2009","journal-title":"Adv. Parasitol."},{"key":"10.1016\/j.vetpar.2024.110113_bib38","series-title":"Digenetic Trematodes","first-page":"78","article-title":"Digenetic trematodes","author":"Mas-Coma","year":"2014"},{"key":"10.1016\/j.vetpar.2024.110113_bib39","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.vetpar.2009.02.004","article-title":"An evaluation of the efficacy of compound alpha and triclabendazole against two isolates of Fasciola hepatica","volume":"162","author":"McConville","year":"2009","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.vetpar.2024.110113_bib40","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1365-2885.1990.tb00773.x","article-title":"The benzimidazole anthelmintic agents-a review","volume":"13","author":"Mckellar","year":"1990","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"10.1016\/j.vetpar.2024.110113_bib41","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0304-4017(97)00108-8","article-title":"Ecotoxicology and residues of anthelmintic compounds","volume":"72","author":"McKellar","year":"1997","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.vetpar.2024.110113_bib42","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.micpath.2017.06.006","article-title":"A review on epidemiology, global prevalence and economical losses of fasciolosis in ruminants","volume":"109","author":"Mehmood","year":"2017","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.vetpar.2024.110113_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1258\/0023677011911345","article-title":"Refining procedures for the administration of substances","volume":"35","author":"Morton","year":"2001","journal-title":"Lab. Anim."},{"key":"10.1016\/j.vetpar.2024.110113_bib44","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1021\/mp070007o","article-title":"Estimation of drug precipitation upon dilution of pH-controlled formulations","volume":"4","author":"Narazaki","year":"2007","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.vetpar.2024.110113_bib45","volume":"volume three","author":"Niazi","year":"2016"},{"key":"10.1016\/j.vetpar.2024.110113_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21218224","article-title":"Pharmaceutical excipients and drug metabolism: a mini-review","volume":"21","author":"Patel","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.vetpar.2024.110113_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2022.121140","article-title":"Pluronics\u00ae based Penta block copolymer micelles as a precursor of smart aggregates for various applications: a review","author":"Patel","year":"2023","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.vetpar.2024.110113_bib48","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.jenvman.2018.11.121","article-title":"Benzimidazoles in wastewater: analytical method development, monitoring and degradation by photolysis and ozonation","volume":"232","author":"Porto","year":"2019","journal-title":"J. Environ. Manag."},{"key":"10.1016\/j.vetpar.2024.110113_bib49","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nrd2468","article-title":"Prodrugs: design and clinical applications","volume":"7","author":"Rautio","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.vetpar.2024.110113_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0207625","article-title":"Chitosan-based nanodelivery systems applied to the development of novel triclabendazole formulations","volume":"13","author":"Real","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.vetpar.2024.110113_bib51","doi-asserted-by":"crossref","first-page":"61","DOI":"10.22319\/rmcp.v8i1.4305","article-title":"Potential economic impact assessment for cattle parasites in Mexico. Review Evaluaci\u00f3n del impacto econ\u00f3mico potencial de los par\u00e1sitos","volume":"8","author":"Rodriguez-Vivas","year":"2017","journal-title":"Rev. Mex. Cien Pec"},{"key":"10.1016\/j.vetpar.2024.110113_bib52","doi-asserted-by":"crossref","first-page":"498","DOI":"10.4236\/pp.2019.1011041","article-title":"Effectiveness of the experimental fosfatriclaben in comparison with two commercial fasciolicides in cattle","volume":"10","author":"Rojas-Campos","year":"2019","journal-title":"Pharmacol. Pharm."},{"key":"10.1016\/j.vetpar.2024.110113_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.vetpar.2021.109524","article-title":"Effectiveness of an experimental injectable prodrug formulation against Fasciola hepatica of different ages in experimentally infected sheep","volume":"298","author":"Rojas-Campos","year":"2021","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.vetpar.2024.110113_bib54","series-title":"in: ADME Processes in Pharmaceutical Sciences: Dosage, Design, and Pharmacotherapy Success","first-page":"97","article-title":"Routes of drug administration","author":"Ruiz","year":"2018"},{"key":"10.1016\/j.vetpar.2024.110113_bib55","first-page":"13","article-title":"Enhancement of oral bioavailability and solid dispersion: a review","volume":"1","author":"Saffoon","year":"2011","journal-title":"J. Appl. Pharm. Sci."},{"key":"10.1016\/j.vetpar.2024.110113_bib56","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1007\/s11094-022-02735-7","article-title":"Using polysorbates to create parenteral dosage forms of hydrophobic substances (A Review)","volume":"56","author":"Sanarova","year":"2022","journal-title":"Pharm. Chem. J."},{"key":"10.1016\/j.vetpar.2024.110113_bib57","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/j.1365-2885.1995.tb00606.x","article-title":"Kinetic disposition of triclabendazole in buffalo compared to cattle","volume":"18","author":"Sanyal","year":"1995","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"10.1016\/j.vetpar.2024.110113_bib58","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.rvsc.2020.10.011","article-title":"Fascioliasis and fasciolopsiasis: current knowledge and future trends","volume":"134","author":"Siles-Lucas","year":"2021","journal-title":"Res. Vet. Sci."},{"key":"10.1016\/j.vetpar.2024.110113_bib59","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.trac.2013.05.006","article-title":"Forced degradation studies to assess the stability of drugs and products","volume":"49","author":"Singh","year":"2013","journal-title":"TrAC Trends Anal. Chem."},{"key":"10.1016\/j.vetpar.2024.110113_bib60","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.addr.2007.05.013","article-title":"Prodrug strategies to overcome poor water solubility","volume":"59","author":"Stella","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.vetpar.2024.110113_bib61","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1007\/978-0-387-49785-3_30","article-title":"Formulation challenges of prodrugs","author":"Strickley","year":"2007","journal-title":"Prodrugs"},{"key":"10.1016\/j.vetpar.2024.110113_bib62","series-title":"Veterinary parasitology","author":"Taylor","year":"2015"},{"key":"10.1016\/j.vetpar.2024.110113_bib63","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0378-5173(99)00307-5","article-title":"Controlled release of vancomycin from poloxamer gels","volume":"192","author":"Veyries","year":"1999","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.vetpar.2024.110113_bib64","doi-asserted-by":"crossref","first-page":"6295","DOI":"10.2147\/IJN.S257269","article-title":"The influence of nanoparticle properties on oral bioavailability of drugs","volume":"15","author":"Wang","year":"2020","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.vetpar.2024.110113_bib65","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0304-4017(95)00806-2","article-title":"World Association for the Advancement of Veterinary Parasitology (W.A.A.V.P.) second edition of guidelines for evaluating the efficacy of anthelmintics in ruminants (bovine, ovine, caprine)","volume":"58","author":"Wood","year":"1995","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.vetpar.2024.110113_bib66","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1124\/dmd.108.026245","article-title":"Evaluation of in vitro models for screening alkaline phosphatase-mediated bioconversion of phosphate ester prodrugs","volume":"37","author":"Yuan","year":"2009","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.vetpar.2024.110113_bib67","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3109\/10717544.2014.891272","article-title":"Poloxamer-based in situ hydrogels for controlled delivery of hydrophilic macromolecules after intramuscular injection in rats","volume":"22","author":"Zhang","year":"2015","journal-title":"Drug Deliv."}],"container-title":["Veterinary Parasitology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304401724000013?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304401724000013?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T01:39:32Z","timestamp":1759628372000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304401724000013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":67,"alternative-id":["S0304401724000013"],"URL":"https:\/\/doi.org\/10.1016\/j.vetpar.2024.110113","relation":{},"ISSN":["0304-4017"],"issn-type":[{"value":"0304-4017","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fosfatriclaben, a prodrug of triclabendazole: Preparation, stability, and fasciolicidal activity of three new intramuscular formulations","name":"articletitle","label":"Article Title"},{"value":"Veterinary Parasitology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vetpar.2024.110113","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110113"}}